Sonoma Pharmaceuticals, Inc.
SNOA • NASDAQ
Sonoma Pharmaceuticals, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Amy Trombly, with a market cap of $3.7M.
Market Cap$3.7M
Employees171.0
CEOAmy Trombly
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsJun 16, 2026 · in 2 monthsQ4 2026
Financials
SNO
Sonoma Pharmaceuticals, Inc. FAQ
Common questions about Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc. is scheduled to report earnings for Q4 2026 on June 16, 2026. Analysts estimate revenue of $5.6M.
Sonoma Pharmaceuticals, Inc. has approximately 171 employees.